Long-Term Effectiveness and Safety of Dexmethylphenidate Extended-Release Capsules in Adult ADHD
Authors:
- 1 March 2009
- journal article
- research article
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 12 (5) , 449-459
Abstract
Objective: This study evaluates dexmethylphenidate extended release (d-MPH-ER) in adults with ADHD. Method: Following a 5-week, randomized, controlled, fixed-dose study of d-MPH-ER 20 to 40 mg/d, 170 adults entered a 6-month open-label extension (OLE) to assess long-term safety, with flexible dosing of 20 to 40 mg/d. Exploratory effectiveness outcomes included change from Week 5 on ADHD Rating Scale (ADHD-RS) and proportion of responders on Clinical Global Impressions—Improvement (CGI-I) scale. Results: 103 patients completed OLE, and effectiveness was evaluable in 102 patients. d-MPH-ER was well tolerated; the most common adverse events (>15%) were headache, insomnia, and decreased appetite. Mean improvements in ADHD-RS score were −10.2 for patients switched from placebo to d-MPH-ER (n = 20) and −8.4 for those maintained on d-MPH-ER (n = 82). Respective CGI-I responder rates were 95.0% and 95.1%. Conclusion: Once-daily d-MPH-ER 20 to 40 mg is safe and effective for long-term treatment of adult ADHD. (J. of Att. Dis. 2009; 12(5) 449-459)Keywords
This publication has 19 references indexed in Scilit:
- Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2007
- The Prevalence and Effects of Adult Attention Deficit/Hyperactivity Disorder on Work Performance in a Nationally Representative Sample of WorkersJournal of Occupational and Environmental Medicine, 2005
- A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderBiological Psychiatry, 2005
- The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general populationPsychological Medicine, 2005
- A Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in Children With Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2004
- Attention-Deficit/Hyperactivity Disorder in AdultsJAMA, 2004
- Stimulant treatment of adult attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004
- Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004
- Nonstimulant treatment of adult attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004
- A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study)Pediatrics, 2004